Seeing Is Believing
RNA is currently covered by 11 analysts with an average price target of $64.21. This is a potential upside of $35.18 (121.18%) from yesterday's end of day stock price of $29.03.
Avidity Biosciences 's activity chart (see below) currently has 32 price targets and 71 ratings on display. The stock rating distribution of RNA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 41.05% with an average time for these price targets to be met of 295.42 days.
Highest price target for RNA is $96, Lowest price target is $53, average price target is $63.18.
Most recent stock forecast was given by ERIC SCHMIDT from CANTOR FITZGERALD on 27-Jun-2025. First documented stock forecast 07-Jul-2020.
Currently out of the existing stock ratings of RNA, 46 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$96
$66.97 (230.69%)
$96
2 days ago
(27-Jun-2025)
0/3 (0%)
$66.97 (230.69%)
Buy
$75
$45.97 (158.35%)
$48
19 days ago
(10-Jun-2025)
2/6 (33.33%)
$41.38 (123.08%)
44
Buy
$75
$45.97 (158.35%)
$65
20 days ago
(09-Jun-2025)
8/14 (57.14%)
$42.34 (129.64%)
299
Buy
$68
$38.97 (134.24%)
$72
1 months 17 days ago
(12-May-2025)
0/5 (0%)
$38.67 (131.84%)
Buy
$60
$30.97 (106.68%)
$60
2 months 20 days ago
(09-Apr-2025)
11/16 (68.75%)
$35.2 (141.94%)
246
What is RNA (Avidity Biosciences ) average time for price targets to be met?
Which analyst has the current highest performing score on RNA (Avidity Biosciences ) with a proven track record?
Which analyst has the most public recommendations on RNA (Avidity Biosciences )?
Which analyst is the currently most bullish on RNA (Avidity Biosciences )?
Which analyst is the currently most reserved on RNA (Avidity Biosciences )?